27.05.2020 | Letter to the Editor
Comment on: “Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study”
Erschienen in: Targeted Oncology | Ausgabe 3/2020
Einloggen, um Zugang zu erhalten